A
Anhui Ronds Science & Technology Inc Co
SSE:688768
Anhui Ronds Science & Technology Inc Co
SSE:688768
Price:
45.61
CNY
5.55%
Market Closed
Market Cap:
¥4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Anhui Ronds Science & Technology Inc Co
SSE:688768
|
CN |
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
|
CN |
|
Aspira Pathlab & Diagnostics Ltd
BSE:540788
|
IN |
|
Gurunavi Inc
TSE:2440
|
JP |
|
J
|
Jastrzebska Spolka Weglowa SA
WSE:JSW
|
PL |
|
Asbury Automotive Group Inc
NYSE:ABG
|
US |
|
Aspen Aerogels Inc
NYSE:ASPN
|
US |
Cash Flow Statement
Cash Flow Statement
Anhui Ronds Science & Technology Inc Co
Anhui Ronds Science & Technology Inc Co
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
17
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(34)
|
(20)
|
(24)
|
(20)
|
(30)
|
(29)
|
(20)
|
(21)
|
(14)
|
(18)
|
(23)
|
(19)
|
(24)
|
(28)
|
|
| Change in Working Capital |
(202)
|
(174)
|
(185)
|
(207)
|
(215)
|
(270)
|
(305)
|
(315)
|
(312)
|
(274)
|
(257)
|
(274)
|
(293)
|
(318)
|
|
| Cash from Operating Activities |
5
N/A
|
22
+318%
|
(1)
N/A
|
(30)
-5 000%
|
(39)
-31%
|
(64)
-63%
|
(71)
-10%
|
(74)
-5%
|
(64)
+14%
|
(32)
+50%
|
(1)
+98%
|
72
N/A
|
104
+46%
|
123
+18%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(15)
|
(19)
|
(28)
|
(33)
|
(37)
|
(38)
|
(47)
|
(49)
|
(58)
|
(54)
|
(35)
|
(39)
|
(28)
|
(26)
|
|
| Other Items |
(114)
|
(104)
|
(73)
|
(52)
|
48
|
93
|
113
|
103
|
0
|
38
|
(54)
|
1
|
(60)
|
(106)
|
|
| Cash from Investing Activities |
(129)
N/A
|
(123)
+5%
|
(101)
+18%
|
(85)
+16%
|
10
N/A
|
55
+427%
|
66
+20%
|
54
-19%
|
24
-55%
|
(16)
N/A
|
(89)
-459%
|
(39)
+57%
|
(88)
-129%
|
(132)
-50%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Debt |
0
|
10
|
30
|
0
|
20
|
30
|
0
|
57
|
57
|
30
|
20
|
(81)
|
0
|
(24)
|
|
| Cash Paid for Dividends |
0
|
(12)
|
(12)
|
(12)
|
(12)
|
(31)
|
(31)
|
(30)
|
(30)
|
(9)
|
(9)
|
(10)
|
0
|
(37)
|
|
| Other |
0
|
196
|
(1)
|
19
|
18
|
24
|
24
|
4
|
5
|
(1)
|
(1)
|
155
|
155
|
163
|
|
| Cash from Financing Activities |
0
N/A
|
195
N/A
|
18
-91%
|
7
-59%
|
(4)
N/A
|
(7)
-86%
|
(37)
-433%
|
31
N/A
|
31
0%
|
20
-37%
|
10
-48%
|
65
+539%
|
75
+17%
|
102
+35%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
72
N/A
|
94
+31%
|
(84)
N/A
|
(108)
-29%
|
(33)
+70%
|
(16)
+50%
|
(42)
-159%
|
11
N/A
|
(8)
N/A
|
(28)
-241%
|
(80)
-182%
|
98
N/A
|
92
-6%
|
93
+1%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(10)
N/A
|
3
N/A
|
(29)
N/A
|
(63)
-119%
|
(77)
-22%
|
(102)
-33%
|
(118)
-15%
|
(123)
-4%
|
(122)
+1%
|
(86)
+29%
|
(35)
+59%
|
32
N/A
|
76
+134%
|
96
+27%
|
|
Switch to:
Switch to:
See Also
Discover More
